person
Aude F.
- Country
- France
- Department
- Oncologie médicale-Urologie
Research Overview
assignment
55
Clinical Trials ·
- Phase II Study of Inavolisib and Enzalutamide Versus Physician's Choice of ARPI or Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1 Study of Valemetostat and Darolutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
- A Phase 3 Study of MK-2870 Versus Investigator’s Choice of Non-platinum Chemotherapy in Participants with Pretreated Locally Advanced or Metastatic Urothelial Carcinoma
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
379
Sites with multiple studies
Has run more than one trial at 379 of 616 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating advanced urothelial carcinoma and bladder cancer, with particular focus on developing innovative therapeutic approaches for patients with muscle-invasive and metastatic disease.
- HER2-expressing urothelial cancers
- Immunotherapy combinations for bladder cancer
- Advanced treatment protocols for metastatic disease
Prostate Cancer Research
The investigator focuses on treating various stages of prostate cancer, particularly metastatic castration-resistant prostate cancer and castration-sensitive prostate cancer.
- Novel hormonal therapy approaches
- Targeted molecular treatments
- Advanced therapeutic combinations
Specialized Oncology
The investigator has expertise in treating germ cell tumors and developing treatment protocols for complex urological malignancies.
- Salvage treatment strategies
- Progressive disease management
- Multi-modal therapy approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.